These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28521201)

  • 1. Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression.
    Yamada Y; Ishikawa T; Harashima H
    Biomaterials; 2017 Aug; 136():56-66. PubMed ID: 28521201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease.
    Ishikawa T; Somiya K; Munechika R; Harashima H; Yamada Y
    J Control Release; 2018 Mar; 274():109-117. PubMed ID: 29408532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector.
    Yasuzaki Y; Yamada Y; Ishikawa T; Harashima H
    Mol Pharm; 2015 Dec; 12(12):4311-20. PubMed ID: 26567847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
    Addison CL; Hitt M; Kunsken D; Graham FL
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
    Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
    Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
    Liu BH; Wang X; Ma YX; Wang S
    Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
    Harms JS; Splitter GA
    Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Status and gene transfer experiments using CMV enhancer/promoter.
    Allamane S; Ratel D; Jourdes P; Berger F; Benabid AL; Wion D
    Biochem Biophys Res Commun; 2001 Jan; 280(1):45-7. PubMed ID: 11162475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of TTR and CMV promoters in vivo and in vitro via a secreted luciferase reporter system].
    Luo ST; Tian WH; Wang G; Dong XY; Yang L; Wu XB
    Bing Du Xue Bao; 2009 Nov; 25(6):424-9. PubMed ID: 20077932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines.
    Luo P; Reed BD; Tsang TC; Harris DT; Flavell RA
    DNA Cell Biol; 2006 Dec; 25(12):659-67. PubMed ID: 17184167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional promoter testing using a modified lentiviral transfer vector.
    Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
    Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes.
    Wang S; Ma N; Gao SJ; Yu H; Leong KW
    Mol Ther; 2001 May; 3(5 Pt 1):658-64. PubMed ID: 11356070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional plasmid DNAs with a CpG-containing backbone achieve durable transgene expression in mouse liver.
    Suzuki T; Wakao Y; Goda T; Kamiya H
    J Gene Med; 2020 Jan; 22(1):e3138. PubMed ID: 31696985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
    Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
    Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells.
    Tang DC; Jennelle RS; Shi Z; Garver RI; Carbone DP; Loya F; Chang CH; Curiel DT
    Hum Gene Ther; 1997 Nov; 8(17):2117-24. PubMed ID: 9414259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.